BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34972204)

  • 1. Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics.
    Migdady Y; Pang Y; Kalsi SS; Childs R; Arai S
    Blood Adv; 2022 Apr; 6(8):2707-2721. PubMed ID: 34972204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zaimoku Y; Takami A; Sato H; Utsumi M; Nakao S
    Int J Hematol; 2013 Jul; 98(1):96-101. PubMed ID: 23661033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ABO incompatibility and complications in hematopoietic stem cell transplantation].
    Jiménez-Ochoa MA; Contreras-Serratos MM; González-Bautista ML; López-Macías C; Torres-Fierro A; Urbina-Escalante E
    Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(Suppl 1):S12-S18. PubMed ID: 36378017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
    Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Cao J; Lu S; Luo D; Pei R; Lu Y; Chen D; Du X; Li S
    Transfusion; 2024 Mar; 64(3):510-516. PubMed ID: 38351735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood group mismatched hematopoietic stem cell transplantation.
    Tekgündüz SA; Özbek N
    Transfus Apher Sci; 2016 Feb; 54(1):24-9. PubMed ID: 26810142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
    Fan H; Jing Y; Li HH; Lu XC; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):364-7. PubMed ID: 18426666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia.
    Ma YR; Wang WJ; Cheng YF; Zhang YY; Mo XD; Han TT; Wang FR; Yan CH; Sun YQ; Chen YH; Wang JZ; Tang FF; Han W; Wang Y; Zhang XH; Huang XJ; Xu LP
    Bone Marrow Transplant; 2020 Jun; 55(6):1068-1075. PubMed ID: 31932654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
    Stussi G; Halter J; Schanz U; Seebach JD
    Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
    Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hemolytic anemia following allogeneic stem cell transplantation.
    Holbro A; Passweg JR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():378-84. PubMed ID: 26637746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.
    Kako S; Kanda Y; Oshima K; Nishimoto N; Sato H; Watanabe T; Hosoya N; Motokura T; Miyakoshi S; Taniguchi S; Kamijo A; Takahashi K; Chiba S; Kurokawa M
    Am J Hematol; 2008 Mar; 83(3):247-9. PubMed ID: 17918251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant.
    Vivero A; Peedin AR; Gao Y; Karp JK
    J Clin Apher; 2023 Aug; 38(4):495-499. PubMed ID: 36703597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passenger lymphocyte syndrome after ABO-incompatible allogeneic hematopoietic stem cell transplantation; dynamics of ABO allo-antibody and blood type conversion.
    Teshigawara-Tanabe H; Hagihara M; Matsumura A; Takahashi H; Nakajima Y; Miyazaki T; Kamijo A; Yamazaki E; Fujimaki K; Matsumoto K; Nakajima H
    Hematology; 2021 Dec; 26(1):835-839. PubMed ID: 34672906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
    Busca A; Dellacasa C; Giaccone L; Manetta S; Biale L; Godio L; Aydin S; Festuccia M; Brunello L; Bruno B
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1765-1770. PubMed ID: 29684566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.